“Cardiovascular safety of tyrosine kinase inhibitors: Putting their ‘QT-phobia’ in perspective”, ADMET DMPK, vol. 4, no. 3, pp. 212–231, Oct. 2016, doi: 10.5599/admet.4.3.295.